{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T01:49:27Z","timestamp":1648950567477},"reference-count":29,"publisher":"Japan Society for Clinical Immunology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2014]]},"DOI":"10.2177\/jsci.37.83","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T23:08:37Z","timestamp":1400195317000},"page":"83-89","source":"Crossref","is-referenced-by-count":1,"title":["Chemokine receptor expression of T cells in the cerebrospinal fluid of relapsing multiple sclerosis"],"prefix":"10.2177","volume":"37","author":[{"given":"Wakiro","family":"SATO","sequence":"first","affiliation":[{"name":"National Institute of Neuroscience, Department of Immunology, National Center of Neurology and Psychiatry (NCNP)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) McFarland, H.F., et al.: Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol<\/i>. 8<\/b>: 913-919, 2007."},{"key":"2","unstructured":"2) Trapp, B.D., et al.: Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci<\/i>. 31<\/b>: 247-269, 2008."},{"key":"3","unstructured":"3) Weiner, H.L.: The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol<\/i>. 65<\/b>: 239-248, 2009."},{"key":"4","unstructured":"4) Sawcer, S., et al.: Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature<\/i>. 476<\/b>: 214-219, 2011."},{"key":"5","unstructured":"5) Sato, W., et al.: CCR2+CCR5+ T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis. J Immunol<\/i>. 189<\/b>: 5057-5065, 2012."},{"key":"6","unstructured":"6) Mackay, C.R.: Chemokines: immunology's high impact factors. Nat Immunol<\/i>. 2<\/b>: 95-101, 2001."},{"key":"7","unstructured":"7) Sallusto, F., et al.: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature<\/i>. 401<\/b>: 708-712, 1999."},{"key":"8","unstructured":"8) Sallusto, F., et al.: Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev<\/i>. 177<\/b>: 134-140, 2000."},{"key":"9","unstructured":"9) Nagata, K., et al.: Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol<\/i>. 162<\/b>: 1278-1286, 1999."},{"key":"10","unstructured":"10) Sato, W., et al.: Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J Immunol<\/i>. 178<\/b>: 7525-7529, 2007."},{"key":"11","unstructured":"11) Acosta-Rodriguez, EV., et al.: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol<\/i>. 8<\/b>: 639-646, 2007."},{"key":"12","unstructured":"12) Singh, S.P., et al.: Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol<\/i>. 180<\/b>: 214-221, 2008."},{"key":"13","unstructured":"13) Lee, Y., et al.: Induction and molecular signature of pathogenic TH17 cells. Nat immunol<\/i>. 13<\/b>: 991-999, 2012."},{"key":"14","unstructured":"14) Ghoreschi, K., et al.: Generation of pathogenic TH17 cells in the absence of TGF-\u03b2 signalling. Nature<\/i>. 467<\/b>: 967-971, 2010."},{"key":"15","unstructured":"15) Peters, A., et al.: The many faces of Th17 cells. Cur Opin Immunol<\/i>. 23<\/b>: 702-706, 2011."},{"key":"16","unstructured":"16) Ramesh, R., et al.: Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med<\/i>. 211<\/b>: 89-104, 2014."},{"key":"17","unstructured":"17) Tzartos, J.S., et al.: Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis. Am J Pathol<\/i>. 172<\/b>: 146-155, 2007."},{"key":"18","unstructured":"18) Brucklacher-Waldert, V., et al.: Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain<\/i>. 132<\/b>: 3329-3341, 2009."},{"key":"19","unstructured":"19) Engelhardt, B.: T cell migration into the central nervous system during health and disease: Differen molecular keys allow access to different central nervous system compartments. Clin Exp Neurommunol<\/i>. 1<\/b>: 79-93, 2010."},{"key":"20","unstructured":"20) Reboldi, A., et al.: CC chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol<\/i>. 10<\/b>: 514-523, 2009."},{"key":"21","unstructured":"21) Kebir, H., et al.: Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med<\/i>. 13<\/b>: 1173-1175, 2007."},{"key":"22","unstructured":"22) Ifergan, I., et al.: The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain<\/i>. 131<\/b>: 785-799, 2008."},{"key":"23","unstructured":"23) Sorensen, T.L., et al.: Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest<\/i>. 103<\/b>: 807-815, 1999."},{"key":"24","unstructured":"24) Leppert, D., et al.: Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain<\/i>. 121<\/b> (Pt 12): 2327-2334, 1998."},{"key":"25","unstructured":"25) Stuve, O., et al.: Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol<\/i>. 40<\/b>: 853-863, 1996."},{"key":"26","unstructured":"26) Chabas, D., et al.: The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science<\/i>. 294<\/b>: 1731-1735, 2001."},{"key":"27","unstructured":"27) Zhang, H.H., et al.: CCR2 identifies a stable population of human effector memory CD4+ T cells equipped for rapid recall response. J Immunol<\/i>. 185<\/b>: 6646-6663, 2010."},{"key":"28","unstructured":"28) Mellado, M., et al.: Chemokine receptor homo - or heterodimerization activates distinct signaling pathways. EMBO J<\/i>. 20<\/b>: 2497-2507, 2001."},{"key":"29","unstructured":"29) Gouwy, M., et al.: Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response. Immunology Lett<\/i>. 145<\/b>: 10-14, 2012."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/2\/37_83\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:56:42Z","timestamp":1621486602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/2\/37_83\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.37.83","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}